Cagrilintide is not associated with clinically relevant QTc prolongation: A thorough QT study in healthy participants.
Maria Buur Nordskov GabeRainard FuhrAngela SinnAstrid EliasenKasper K BerthelsenAnja B KuhlmanTine A BaekdalAyna B NejadPublished in: Diabetes, obesity & metabolism (2024)
Cagrilintide did not result in clinically relevant QTcF prolongation, indicating no increased risk of ventricular tachyarrhythmias.